The FDA is investigating 127 cases of e-cigarette users experiencing seizures by lisettevoytko
of e-cigarette users experiencing seizures, and hasn’t detected a pattern among the reports, as scientists have yet to fully determine the long-term health impact of vaping.
The FDA announced in April that it was investigating 32 reports of people suffering seizures after vaping. Since then, 92 more reports were made to the agency. The cases occurred from 2009 to 2019 among youth users and adults, and the FDA said it’s unclear if e-cigarettes caused the seizures.In addition, the FDA said in some of the cases, users had pre-existing seizure diagnoses, or used additional drugs, like marijuana, along with the e-cigarettes., as well as dizziness, nausea, tremors, or even death.—and that e-cigarettes are a less dangerous nicotine source than tobacco cigarettes, but recommends that nonsmokers stay away from vaping.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA investigating 127 reports of seizures after vapingThe FDA cautions it's unclear whether e-cigarettes caused the seizures.
Leer más »
FDA investigating 127 reports of vaping-related seizures, neurological symptomsThe US Food and Drug Administration has received 127 reports of seizures or other neurological symptoms possibly related to e-cigarettes, the agency announced Wednesday. Investigators have yet to determine, however, whether vaping was directly linked to the cases.
Leer más »
FDA investigating 127 reports of seizures, other neurological symptoms after vapingFDA investigating 127 reports of people suffering seizures or other neurological symptoms after using e-cigarettes, agency announces.
Leer más »
Company knew about manipulated data before FDA approved $2 million gene therapy, agency saysThe maker of Zolgensma, a gene therapy for babies, did not inform federal regulators about 'data manipulation that created inaccuracies' until after its $2.1 million treatment was approved, the US Food and Drug Administration said Tuesday.
Leer más »
FDA raises accuracy questions over trial data of $2 million gene therapy drugMore than 2 months after the FDA approved an expensive new gene therapy drug for a rare disease in children, the agency said it has major questions about the accuracy of some of the testing data.
Leer más »
FDA Says Data Manipulated for Novartis Gene Therapy DrugThe Food and Drug Administration said “data manipulation” took place during the clinical trial of Zolgensma, the world’s most expensive drug, but officials said the gene therapy product still should stay on the market.
Leer más »